Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Fielmann Group AG's Equity-to-Asset or its related term are showing as below:
XSWX:FIE'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.38 Med: 0.51 Max: 0.77
Current: 0.4
During the past 13 years, the highest Equity to Asset Ratio of Fielmann Group AG was 0.77. The lowest was 0.38. And the median was 0.51.
XSWX:FIE's Equity-to-Asset is ranked worse than 76.17% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 0.645
vs XSWX:FIE: 0.40
Fielmann Group AG (XSWX:FIE) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Fielmann Group AG Equity-to-Asset Related Terms
Fielmann Group AG Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Fielmann Group AG's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:FIE vs ISRG, BDX, MDLN: Equity-to-Asset Comparison
For the Medical Instruments & Supplies subindustry, Fielmann Group AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fielmann Group AG Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fielmann Group AG's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Fielmann Group AG's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Fielmann Group AG's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fielmann Group AG (XSWX:FIE) has a Equity-to-Asset of 0.00 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Fielmann Group AG and its competitors. Over the past decade, Fielmann Group AG's Equity-to-Asset has ranged from 0.38 to 0.77. According to the industry distribution chart, Fielmann Group AG ranks #649 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 76.2%.
Is Fielmann Group AG's Equity-to-Asset too high?
Fielmann Group AG's current Equity-to-Asset is 0.00. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 0.77. Based on the distribution chart, Fielmann Group AG ranks #649 out of 852 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Fielmann Group AG has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Fielmann Group AG's Equity-to-Asset compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fielmann Group AG ranks #649 out of 852 companies for Equity-to-Asset. This places Fielmann Group AG in the lower half of its industry. The industry median Equity-to-Asset is 0.65. Historically, Fielmann Group AG's own Equity-to-Asset has ranged from 0.38 to 0.77 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.65, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Fielmann Group AG and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fielmann Group AG's current Equity-to-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fielmann Group AG stock overvalued right now?
Fielmann Group AG (XSWX:FIE) has a current Equity-to-Asset of 0.00. The stock's GF Value™ is CHF50.45, compared to a current price of CHF37.15 — trading 26.4% below its estimated fair value. The current Equity-to-Asset is 0.00. Fielmann Group AG's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Fielmann Group AG (XSWX:FIE), the current Equity-to-Asset is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fielmann Group AG (XSWX:FIE) Overvalued in 2026?
Based on GuruFocus' analysis, Fielmann Group AG stock appears to be undervalued.
The current stock price of CHF37.15 is trading 26.4% below its estimated GF Value™ of CHF50.45.
Key valuation signals for XSWX:FIE:
Equity-to-Asset: 0.00
GF Value™: CHF50.45 vs. price of CHF37.15 (26.4% below fair value)
No single metric tells the full story. See the XSWX:FIE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fielmann Group AG is involved in the purchase and sale of goods, in physical stores as well as wholesale and online, particularly in the optometric and hearing acoustics sectors, and especially sales of all kinds of vision aids - particularly glasses, eyeewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems, as well as personal protective equipment. Fielmann is involved in all levels of the optical industry value-added chain: designing, manufacturing, product offering, and optician services. The group was divided into six segments: Germany, Switzerland, Austria, Spain, North America, and Other. The majority of its revenue is generated from Germany.
84GF Score
Get the complete analysis for XSWX:FIE
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FIE has been successfully added to your 
